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Abstract
Background: N-acylethanolamines (NAEs) are endogenous compounds that regulate inflammation and pain. These include
the cannabinoid ligand anandamide (AEA) and the peroxisome proliferator-activated receptor-a ligand palmitoylethano-
lamide (PEA). Little is known as to the levels of NAEs in pain states in human, particularly in the skeletal muscle. The aim of
this study was to investigate the levels of these lipid mediators in muscle dialysate from women with chronic neck-/shoulder
pain compared to healthy controls.
Methods: Eleven women with chronic neck-/shoulder pain and eleven healthy women participated in this study. All
participants went through microdialysis procedures in the trapezius muscle. Muscle dialysate samples were collected during
four hours and analysed by nano liquid chromatography tandem mass spectrometry (nLC-MS/MS).
Results: We were able to detect AEA, PEA, N-stearoylethanolamine (SEA) and 2-arachidonoylglycerol (2-AG) in a single
chromatographic run. Of the NAEs studied, PEA and SEA were clearly detectable in the muscle microdialysate samples. The
muscle dialysate levels of PEA and SEA were significantly higher in myalgic subjects compared to healthy controls.
Conclusion: This study demonstrates that microdialysis in combination with mass spectrometry can be used for analysing
NAE’s in human muscle tissue regularly over time. Furthermore the significant group differences in the concentration of PEA
and SEA in this study might fill an important gap in our knowledge of mechanisms in chronic myalgia in humans. In the long
run this expanded understanding of nociceptive and anitinociceptive processes in the muscle may provide a base for
ameliorating treatment and rehabilitation of pain.
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Introduction
Chronic pain is associated with disability, low quality of life and
substantial socioeconomic costs. Common chronic pain conditions
are localized neck-shoulder pain including trapezius myalgia,
which has a prevalence of 10–20% in the community [1]. A bio-
psycho-social model [2,3] is preferred in clinical management of
chronic pain since a complex blend of factors - neurobiological,
psychological, coping styles, and contextual factors - contributes to
the development and maintenance of chronic pain [4,5,6,7,8].
There are several indications that central alterations in nociceptive
processing can be driven by peripheral tissue alterations [9] and
peripheral nociceptive input [10,11] also in the chronic stage of a
pain condition. However, the understanding of mechanisms,
including the peripheral balances between nociceptive and
anitinociceptive processes, behind chronic myalgia is incomplete.
Muscle nociception is activated by stimulation of free nerve
endings of group III (Ad) and IV afferent (C) fibers. Based on
animal experiments and infusion of different substances into
human muscles it is known that nociceptors respond to single or
combinations of noxious stimuli: mechanical, temperature, and
chemical (i.e., algesics such as serotonin, bradykinin, glutamate
and substance P) [12]. The sensitivity of the nociceptors can be
increased by endogenous substances [12].
The microdialysis technique offers a well-established in vivo
method to study nociceptive and metabolic mechanisms [13,14].
The trapezius muscle can be used as a human model muscle of
chronic myalgia both due to its clinical importance and to its
accessibility for invasive investigations. Investigating chronic
trapezius myalgia using microdialysis techniques, we and others
PLoS ONE | www.plosone.org 1 November 2011 | Volume 6 | Issue 11 | e27257have reported significantly increased interstitial levels of different
algesics indicating activated peripheral nociceptive processes
[15,16,17].
Whilst the microdialysis studies of myalgic muscles so far
undertaken implicate changes in algesic signalling as a key event,
little is known about changes in the pain-inhibitory signalling
molecules. One interesting group of such molecules are the N-
acylethanolamines (NAEs), a family of endogenous lipid medi-
ators that have a diversity of actions including the regulation of
inflammation and pain [18]. Among the NAEs are N-palmitoy-
lethanolamine (PEA), N-stearoylethanolamine (SEA), N-oleoy-
lethanolamine (OEA) and N-arachidonoylethanolamine (ana-
ndamide, AEA). The most well-studied of the NAEs is AEA,
which interacts with cannabinoid receptors and at higher
concentrations other targets including transient receptor poten-
tial (vanilloid-1) receptors, and has been shown to have anti-
nociceptive actions in a number of animal models of pain [19].
However, in most tissues, the concentration of AEA is much
lower than of PEA, which has been shown to have both anti-
inflammatory and anti-nociceptive effects in several pain models
[20,21,22,23,24], possibly due to its ability to interact with
peroxisome proliferator-activated receptor a.O E Ai sa l s oa
ligand for this receptor, but has mainly been investigated with
respecttofeeding behaviour[25],while muchlessis knownabout
the in vivo functions of the other NAEs.
In view of the potential role of NAEs in the control of pain, the
aim of this study was to investigate the levels of NAEs in human
muscle microdialysate using a high sensitive liquid chromatogra-
phy tandem mass spectrometry (nLC-MS/MS) method and to
utilise it to determine whether NAE levels are altered in patients
with myalgia.
Materials and Methods
Study design and procedures
Participants with and without chronic neck-shoulder pain were
recruited via advertisements in the local daily newspaper. Those
who responded received an invitation letter with information
about the study. A self-reported pain questionnaire together with a
structured telephone interview was used for primary screening in
order to assess eligibility. Eligible patients were invited for a
standardized clinical neck and shoulder examination in order to
confirm inclusion and exclusion criteria. Consecutive enrolment
was applied and the time between clinical examination and
microdialysis examination of the trapezius muscle was one to four
weeks.
Participants
Subjects with chronic pain. Eleven women with chronic
pain in neck/shoulder area participated in the study. Inclusion
criteria were female sex, age range 20–55 years, and pain in the
neck-/shoulder area that had lasted more than six months.
Exclusion criteria were generalized pain such as fibromyalgia,
upper extremity bursitis, tendonitis, capsulitis, postoperative
conditions in the neck/shoulder area, prior neck trauma,
disorder of the spine, neurological disease, rheumatoid arthritis
or any other systemic diseases, metabolic disease, malignancy,
severe psychiatric illness, pregnancy, BMI.35, and difficulties
understanding the Swedish language. Median age and median
body mass index (BMI) noted in the records was 45 years and
23.2 kg/m
2, respectively (Table 1).
Pain-free subjects. Eleven pain-free women comprised a
comparison group. Inclusion criteria were female sex, age range
20–55 years and pain-free. The exclusion criteria were as above,
and additionally pain that had lasted more than seven days during
the past 12 months. Median age and median BMI was 41 years
and 24.0 kg/m
2, respectively (Table 1).
No significant differences between groups existed with respect to
age and anthropometric variables (Table 1).
Anthropometric data together with age and pain duration are
reported in table 1 for the two groups.
Ethical approval of the study
After receiving verbal and written information about the study,
all subjects signed a consent form that was in accordance with the
Declaration of Helsinki. The study was granted ethical clearance
by the Linko ¨ping University Ethics Committee (Dnr: M10-08).
Methods
Self-reported pain questionnaire
The Nordic Ministry Council Questionnaire (NMCQ) was used
[26]. This is a well-established self-reported pain questionnaire
allowing assessment of low back, neck, shoulder and general
complaints. It includes symptoms (ache, pain, and discomfort)
arising from nine well defined anatomical regions over the past 12
months and the previous seven days.
Standardized clinical neck and shoulder examination
In order to confirm eligibility for inclusion in the study, all
participants were examined by a standardized and validated
clinical examination according to Ohlsson et al. [27]. The
examination includes questions on pain, tiredness and stiffness
Table 1. Age, anthropometric data and pain duration in the two groups (median, maximum and minimum values).
Variables Group Statistics
Controls Chronic Pain
Median Minimum Maximum Median Minimum Maximum p-value
Age (years) 41 26 54 45 26 55 0.576
Height (cm) 169 155 177 168 154 172 0.449
Weight (kg) 68 55 98 61 57 79 0.470
BMI (kg/m
2) 24,0 21,9 31,2 23,2 19,9 29,3 0.375
Pain duration (months) NA NA NA 51 9 252 NA
Furthest to the right is given the results of the statistical analyses.
NA=not applicable.
doi:10.1371/journal.pone.0027257.t001
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range of motion and tightness of muscles, pain threshold and
sensitivity, muscle strength and palpation of tender points. Patients
with trapezius myalgia that were included in the study had neck
pain at the examination day, tightness of the trapezius muscle, i.e.,
a feeling of stiffness in the descending region of the trapezius
muscle reported by the subject at examination of lateral flexion of
the head, and palpable tender parts in the trapezius muscle. The
range of motion of the cervical columna was normal or slightly
decreased.
The microdialysis technique
The technique of microdialysis enables the monitoring of
different substances in the extracellular environment and is now
widely used for sampling and quantitating neurotransmitters,
neuropeptides, and other substances in the brain and periphery.
Briefly a microdialysis system consists of the microdialysis pump,
the microdialysis catheter and a microvial in which the sample is
collected. During the process of microdialysis the catheter is
inserted in the tissue of interest and is perfused with a solution
(termed perfusate) that resembles the interstitial fluid. Substances
diffuse into or out of the perfusion fluid in a concentration-
dependent manner and dialysate samples can be collected [28].
Experimental procedure
The participants were asked not to take non-steroidal anti-
inflammatory drugs for the last seven days and/or paracetamol
medication for the last 12 hours before the experiment. In
addition, they were asked not to consume coffee and/or tea and
cigarettes and/or nicotine agents for the last eight hours before the
experiment. They were also instructed not to perform any
shoulder or neck-straining exercises for the last 48 hours before
the study, except for ordinary daily work and/or leisure activities.
The participants reported to the laboratory in the morning. The
examiner went through a checklist in order to assess whether or
not participants had followed the instructions, and their current
health status as well as current medication was confirmed. The
most painful side (subjects with pain) or the dominant side (pain
free subjects) of the trapezius muscle was used for microdialysis
procedures. To guide the placement of catheters, ultrasonographic
measurements of the trapezius muscle area were conducted. The
B-scan application was used measuring skin/fat/muscle thickness
of the trapezius muscle area with a 7 MHz linear probe. Tissue
thickness was determined as the distance between the skin surface
and the initial hypo-echoic structure (skin), the distance within the
hypo-echoic structure (fat) and the distance between the fascias
(muscle).
The skin and the subcutaneous tissues above, where the catheter
entered the trapezius muscle were anaesthetized with a local
injection (0.5 ml) of Xylocaine (20 mg/ml) without adrenaline,
and care was taken not to anaesthetize the underlying muscle.
Two commercially available microdialysis catheters (cut-off points
of 20 and 100 kDa; CMA Microdialysis AB, Solna) were inserted
with a catheter into the pars descendens of the trapezius muscle at
half the distance between the processus spinosus of seventh
cervical spine and the lateral end of the acromion. Typically, a
brief involuntary contraction and change of resistance were
perceived when the tip of the insertion needle of the catheter
entered the fascia and muscle. The catheters were placed in the
trapezius muscle parallel to the muscle fibers and perfused at 5 ml/
min with a solution (perfusate) resembling the muscle interstitial
fluid. The perfusion fluid consisted of Ringer acetate solution
containing 3 mM glucose and 0.5 mM lactate and 0.3 ml/ml
[
14C]- Lactate (specific activity: 5.77 GBq/mmol; Amersham.
Bucks. UK) as well as 0.3 ml/ml
3H2O (specific activity: 37 MBq/
gram) were added to the perfusate used in the microdialysis
catheters. This procedure allows the determination (if necessary, it
turned out not to be the case) as to whether outlier values can be
attributed to technical sampling errors, which would be reflected
in abnormal in vivo relative recovery (RR) rates (calculated from
5 ml samples according to the internal reference method by
Scheller and Kolb [29].
After the insertion of catheters, participants rested comfortably
in an armchair for a 120 min period to allow the tissue to recover
from possible changes in the interstitial environment induced by
the operative procedure. After this period, participants continued
to rest for a 20 minutes of baseline period. This was followed by a
20 min period of standardized repetitive low-force exercise
performed on a pegboard (PEG). The experiment ended with a
recovery period of 120 min during which participants rested.
Immediately prior and after catheter insertion subjects were asked
to rate their pain intensity. They continued to do so every
20 minutes throughout the experiment that lasted four hours. At
20 (i.e. beginning of trauma period), 120 (i.e. after recovery from
the operative procedure), 140 (i.e. baseline), 160 (i.e. low-force
exercise), 180, 200 and 220 min (i.e. recovery period) after the
start of the experiment, microdialysate was collected in glass vials
(CMA Microdialysis, Sweden). Each vial was weighted before and
immediately after sampling order to confirm that sampling was
working according to the perfusion rate set. All samples were
controlled for visible signs of haemolysis that would result in the
discarding of the sample. The samples were stored at 4uC
throughout the experiment and then stored as aliquots 270uC
until analysis.
In a review by Buczynski et.al. in 2010 important factors that
can affect the sampling of extracellular NAE’s and endocannbi-
noids were listed and recommendations were made as to the
optimal sampling procedures [30]. Our study essentially follows
the recommendations made by the review.
Participants were offered a standardized light meal at the
100 min time point. No food or beverages except for water was
allowed otherwise during the experiment.
Standardized low-force repetitive exercise
The low-force exercise consisted of a repetitive arm movement
task that was performed unilaterally using the arm on the same
side as the microdialysis catheter had been inserted in the trapezius
[15]. The subjects moved short wooden sticks (11.8 g) back and
forth between standardized positions 30 cm apart on a pegboard
at a frequency of 1 Hz indicated by an electronic metronome
(Korg Inc., Tokyo, Japan). The participants performed the
exercise in a seated position with the pegboard placed 30 cm in
front of them, measured from the elbow with the upper arm
hanging vertically and the elbow in a 90u flexion. The exercise was
supervised by qualified personnel (e.g. nurse or physiotherapist).
Pain intensity ratings
The subjects were asked to rate their pain intensity on a
numeric rating scale (NRS) with numbers (0–10; 0=no pain and
10=worst possible pain) provided along for guidance. All pain
ratings concerned pain in the trapezius muscle of both the most
painful side (subjects with pain) or the dominant side (pain free
subjects) and the contralateral side.
Analysis of NAE levels
On the day of analysis, 50 ml samples were dried by SpeedVacc.
redissolved in methanol, vortexed and centrifuged. The superna-
tant was analysed by liquid chromatography - tandem mass
NAEs Increased in Human Trapezius Myalgia
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TM (Bruker Dal-
tonics), a nano-flow HPLC system equipped with column 5 mm
C18 (Nano Separations. 360 mm675 mm i.d., 10 cm) coupled to a
mass spectrometer Bruker Daltonics Ultra Performance High
Capacity Ion Trap MS (HCT Ultra) with electrospray ionisation
was used. The compounds were eluted isocratically (acetonitrile
with 0.1% formic acid) at a flow rate of 0.0009 mL min
21. Online
analysis of the NAEs was performed using the ion trap mass
spectrometer HCT Ultra. The mass spectrometer was operated in
the positive ion multiple reaction monitoring mode and the
selected ion pairs used were 348.2/287.1. 300.2/283.1 and 328.3/
311.1 m/z for AEA, PEA and SEA, respectively. The linearity of
the measuring range was assessed with standard curves ranging
from 0.01–20 nM (0.01; 0.012; 0.02; 0.025; 0.05; 0.1; 0.2; 1; 2; 5;
10; 20) in human muscle dialysate. Standard curves generated
using linear regression.
Statistics
Statistical analyses (D’Agostino and Pearson omnibus normality
test, two-tailed Mann-Whitney U-test, Kruskal-Wallis test and
Spearman’s correlation test) were undertaken using the Graphpad
Prism computer programme (GraphPad Software Inc, San Diego,
CA, USA) and the PASW Statistics version 18 (IBM Corporation,
Route 100 Somers, New York, USA).
Results
Measurement of NAEs in microdialysate samples from
trapezius muscle
A bioanalytical method utilizing nLC (liquid chromatography)
MS/MS (tandem mass spectrometry) was used to measure NAEs
and we were able to detect AEA, PEA, 2-AG, SEA, in a single
chromatographic run (see Fig. 1 for a representative chromato-
gram of reference standards). We could also separate these
NAEs from three other NAEs: N-linolenoyl-, N-linoleoyl- and
N- docosahexaenoyl - ethanolamines (data not shown). In initial
pilot studies using pooled microdialysate samples from trapezius
muscle of myalgia patients, however, only two NAEs could be
robustly measured, PEA and SEA, and so we focussed upon these
two in the main study. The linear measuring range for PEA and
SEA was 0.05–20 nM in this study. Figure 2 represents an
example of standard response curves for PEA and SEA in muscle
dialysate from women. The correlation coefficient of calibration
curves (R
2) in the diagrams were $0.9. The limit of detection with
Figure 1. Representative MRM-chromatogram of reference standards. The injection volume was 4 ml for all of them (20 fM). The EASY-
nLC
TM, a nano-flow HPLC system coupled to the mass spectrometer Ion Trap MS (HCT Ultra) was used as described in methods.
doi:10.1371/journal.pone.0027257.g001
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quantitation was about 0.04 nM.
Characterisation of levels of PEA and SEA in trapezius
myalgia
Eleven patients with trapezius myalgia and eleven controls took
part in the study. The pain scores (NRS) for the patients were
relatively stable throughout the study. However, the median pain
intensity increased significantly during the low force exercise in the
patients with trapezius myalgia (baseline (140 min): 5 vs. exercise
(160 min): 6; p=0.028) but not in controls (baseline (140 min): 0
vs. exercise (160 min): 0; p=0.102) (Figure 3; Panel A). The
pain intensity of the contralateral side (i.e., clinically less painful)
was generally lower throughout the experiment and did not show
significant changes throughout the experiment in patients
(Figure 3; Panel B). The median values for the control cases
was 0 at all time points and the range was 0–2 except for the
160 min time point where one case reported a score of 5 on the
dominant side (Figure 3; Panel C).
In all subjects taken together there were no significant
correlations between the concentrations of PEA and SEA and
age or BMI. Higher concentrations of PEA and SEA were found
in the trapezius muscle of pain subjects compared to pain free
subjects. The difference between the groups was significant at all
time points for both substances except for PEA at 140 min
(Table 2). In the pain group there were no significant correlations
between the concentrations of these substances and pain duration
or pain intensity. There were no significant effects of sample time
upon the observed values for NAE, either patients or control cases
(P.0.2), suggesting that the interstitial levels of PEA and SEA
were rather stable and were not affected by the period of
standardized low-force repetitive exercise. Similar results were
obtained when recovery of [
14C] - lactate was used to standardize
the samples (data not shown). Typical chromatograms for PEA
and SEA in dialysate from two myalgic and two control subjects
are shown in Figure 4.
Discussion
The microdialysis technique has been used in a number of pain
conditions in human, such as work-related chronic trapezius
myalgia [15,16,31,32,33,34], chronic whiplash associated disor-
ders (WAD) with involvement of the trapezius [9], chronic
Figure 2. Example of standard response curves of PEA and SEA in human muscle dialysate.
doi:10.1371/journal.pone.0027257.g002
Figure 3. Pain intensity ratings for the myalgia patients and pain-free controls. Pain intensity ratings at the different time points
(P=measurement prior to the surgery) for A, myalgia patients, most painful side; B, myalgia patients, contralateral side; C, pain-free controls,
dominant side. Shown are box plots with the range of scores at each time point, n=10–11. The arrow indicates when the standardized low-force
repetitive exercise was undertaken.
doi:10.1371/journal.pone.0027257.g003
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microdialysis studies report alterations in concentrations of algesic
substances together with metabolic alterations in myalgic muscles.
To date little is known about changes in the pain-inhibitory
signaling molecules in chronic myalgia in humans. In the present
study, we have developed a method allowing determination of
NAEs in small samples of muscle dialysate and used the method to
demonstrate that the levels of PEA and SEA are significantly
elevated in women with chronic trapezius myalgia compared to
healthy controls.
For detection of NAEs and/or endocannabinoids in biological
samples, different analytical methods have been reported in the
literature [37]. Most of the methods use a triple quadrupole
tandem mass spectrometer and detect the typical fragment ion m/
z: 62 which correspond to the protonated ethanolamine from
NAEs. In this study, an alternative MRM (multiple reaction
monitoring) method was developed with increased sensitivity and
specificity with the long-term aim to detect NAEs from single
dialysate samples using an ion-trap mass spectrometer (Figure 1).
Measurement of such lipophilic molecules in microdialysis
experiments is far from easy. Several factors such as composition
and cut-off limit of the dialysate membrane, perfusate composi-
tion, perfusate flowrate, and collection time can effect the sampling
of interstitial NAEs.
The concentration of these lipids in the dialysate samples will
not represents the exact interstitial concentration in the trapezius
muscle. However, this technique enables sampling of substances at
the site of action. Also in this study we have used a membrane with
a low cut-off (20 kDa) and this provides protein-free samples and
prevents enzymatic degradation as soon as the lipids cross the
dialysis membrane.
Recommendations have been made as to optimal sampling
conditions [30]. Essentially following these recommendations, we
have been able to detect PEA and SEA in microdialysis samples
from trapezius muscle, whereas we were not able to detect 2-AG
or AEA. It is possible that further optimization is required to detect
unsaturated NAEs as opposed to the saturated PEA and SEA.
However, in most tissues, AEA levels are an order of magnitude
lower than those of PEA and SEA [38], and so it is unlikely that we
would be able to detect this compound even under optimum
conditions without dramatically increasing the size of our
microdialysate samples. In consequence, we have elected to focus
upon PEA (and SEA), since the small sample sizes allow for
repeated measurements to assess the stability of the measured
levels and to follow the outcome of an intervention, such as the
standardized low-force repetitive exercise paradigm used here.
The present study demonstrates that levels of PEA and SEA are
both increased in dialysate samples from women with chronic
trapezius myalgia compared to healthy controls, and that this
increase is rather stable over time and not obviously affected by
the standardized low-force repetitive exercise work associated with
a significant pain intensity increase. Hence, the elevated levels of
PEA and SEA in chronic trapezius myalgia at rest were apparent,
but these levels did not parallel the significant increase in pain
during the work period. Thus, we could not show definite
alterations in PEA and SEA linked to increased pain intensity
during the work period. One explanation of this is that the levels of
these substances are at maximum attainable in response to the
pathological situation and cannot be further augmented by the
increased pain. The lack of correlations between the concentra-
tions of PEA and SEA and pain intensity and pain duration also
give som support to our explanation. The lack of increases in PEA
and SEA in controls could be due to the fact that the low force
exercise did not elict pain in this group (Figure 3; Panel C). In
future studies of the roles of PEA and SEA in relation to pain a
design including provocation of pain both in healthy subjects and
in patients with chronic pain is preferable. The number of subjects
in this study were relatively low (11+11) which also limits the
possibility to detect alterations in concentrations of PEA and SEA.
Hence, in future studies it will be important to investigate if the
increased levels of PEA and SEA represent a tonic situation or if
also phasic aspects are present in chronic trapezius myalgia.
Table 2. PEA and SEA concentrations (nM) in microdialysis samples from patients with trapezius myalgia and controls.
Time of sample (min after start of experiment)
20) 120 140 160 180 220
beginning of
trauma period
after recovery from the
operative procedure baseline low force exercise recovery period recovery period
PEA
Myalgia 3.3 (0.42–11.9) 1.90 (0.58–4.10) 1.95 (0.10–8.60) 1.60 (0.60–6.60) 2.40 (0.92–6.80) 1.00 (0.40–4.50)
n 11 9 10 9 10 7
Pain free subjects 0.60 (0.10–2.5) 0.73 (0.50–2.50) 0.51 (0.30–3.70) 0.20 (0.10–1.8) 0.50 (0.10–1.2) 0.60 (0.10–0.90)
n 11 8 10 9 11 11
P-value ,0.001 0.011 0.15 ,0.005 ,0.001 0.018
SEA
Myalgia 3.75 (1.4–16.5) 4.80 (0.65–20.0) 2.93 (0.63–18.0) 3.80 (0.20–13.0) 5.40 (0.96–20.0) 1.92 (0.45–12.0)
n 11 9 10 8 10 7
Pain free subjects 0.90 (0.10–2.00) 0.30 (0.10–1.70) 0.45 (0.10–2.1) 0.40 (0.10–2.4) 0.40 (0.10–1.8) 0.20 (0.05–2.00)
n 11 8 10 9 11 11
P-value ,0.001 0.002 0.003 0.018 ,0.002 ,0.01
Shown are median values with range in brackets. P values were determined by two-tailed Mann-Whitney U-test at each time point. For each series, there was no
significant variation of the microdialysate concentrations over time (P.0.2, Kruskal-Wallis test). Non-parametric statistics were chosen since approximately half of the
PEA data series and two of the SEA series (time points and pain conditions analysed separately) did not pass the D’Agostino and Pearson omnibus normality test.
doi:10.1371/journal.pone.0027257.t002
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acute muscle nociception/pain (e.g., using the intramuscular
hypertonic saline model [39,40]) in pain free controls. Only
women were included in this study. In future studies it would be
interesting to analyze these substances in men with chronic
myalgia as well as healthy controls in order to investigate possible
gender differences.
This new data with significant increases in PEA and SEA is of
potential importance not only in diagnostic terms (currently
history-taking and clinical examination are the only methods
available for diagnosing chronic myalgia, and diagnostic bio-
markers are greatly needed) but also in identifying potential
novel therapies, given the analgesic properties of PEA
[20,21,22,23,24,41]. Less is known about SEA, although prelim-
inary data from a model of experimental burn in rats have shown
that SEA externally applied has an anti-inflammatory effect [42].
The large increase in the level of these compounds in myalgic
muscles may reflect an attempt by the body to counteract noxious
processes and activation of nociceptors as a result of the myalgia. If
this is the case, then compounds preventing their breakdown of
PEA and possibly SEA may be useful analgesics for this indication.
PEA is metabolised by two different hydrolytic enzymes, fatty acid
amide hydrolase (which also metabolises SEA) and N-acylethano-
lamine-hydrolyzing acid amidase. Recently, an inhibitor of N-
acylethanolamine-hydrolyzing acid amidase has been described
and shown to have anti-inflammatory properties [43]. Fatty
acid amide hydrolase inhibition has been more extensively
characterised in view of the ability of the enzyme to metabolise
AEA, and inhibitors of this enzyme are currently under
pharmaceutical development as analgesics (see [44]). Although
more work is needed, the present study raises the possibility that
such compounds may have utility in myalgia.
Conclusion
There is a need for a better understanding of nociceptive and
antinociceptive processes in chronic myalgia. The present study
demonstrates that microdialysis in combination with mass
spectrometry can be used for analysing N-acylethanolamines
(NAEs) in human muscle tissue regularly over time. The significant
group differences in the concentration of the pain-inhibitory
signaling molecules PEA and SEA might fill an important gap in
our knowledge of mechanisms in chronic myalgia in humans. In
the long run an expanded understanding of anitinociceptive
processes in the muscle may provide a base for ameliorating
treatment and rehabilitation of chronic pain conditions.
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